Prognostic implication of Ki-67 immunostaining in treating subclinical pleural cancer found at thoracotomy in lung cancer patients

Annals of Thoracic Surgery

Volumn 71, Issue 6, 2001, Pages 1765-1771

  Shiba, Mitsutoshi ^a   Kakizawa, Kimitaka ^a   Kohno, Hiromasa ^a   Shibuya, Kiyoshi ^a   Yamakawa, Hisami ^a   Hiroshima, Kenzo ^a   Fujisawa, Takehiko ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADULT; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; THORACOTOMY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT PLANNING;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL DIVISION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PLEURA; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; PNEUMONECTOMY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034983938     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)02589-9     Document Type: Article

References (20)

1. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
2. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections
3. Cell proliferation kinetics in human solid tumors: Relation to probability of metastatic dissemination and long-term survival
4. Ki-67 immunostaining and survival in operable lung cancer
5. Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer
6. Prognostic significance of Ki67 labelling in resected non small cell lung cancer
7. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression
8. Revisions in the international system for staging lung cancer
9. Nonparametric estimation from incomplete observations
10. Regression models and life tables
11. Lung cancer and pleural effusion. Clinical significance and study of pleural metastatic lesions
12. The malignant pleural effusion. A review of cytopathologic diagnosis of 584 specimens from 472 consecutive patients
13. Pleurectomy in the treatment of pleural effusion due to metastatic malignancy
14. Indications for pleurectomy in malignant effusion
15. Neoadjuvant chemotherapy and operations in the treatment of lung cancer with pleural effusion
16. Long-term results of postoperative intrathoracic chemothermotherapy for lung cancer with pleural dissemination
17. Pleural dissemination in non-small cell lung cancer: Results of radiological evaluation and surgical treatment
18. Comparison of pleuropneumonectomy and limited surgery for lung cancer with pleural dissemination
19. Value of Ki-67 immunostaining in preoperative biopsies of carcinomas of the lung
20. An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during surgery